CDKN2A and glioma: Genetic analyses over the past several years have defined the major targets that are associated with the formation of glioma including EGRF, PTEN, TP53, IDH1/2, CDKN2A, MGMT, and others [42], which likely have downstream effects on other genes to improve tumor survival.